Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”

P.A. Schnabel (Heidelberg, Germany)

Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Session: Hot topics in molecular pathology and functional genomics of lung cancer
Session type: Oral Presentation
Number: 3252

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P.A. Schnabel (Heidelberg, Germany). Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”. Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD – will new insights into molecular pathology define new therapies?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014


New findings in the molecular biology of lung cancer: clinical application
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Omics in population studies: a molecular epidemiology perspective in chronic airway disease
Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome
Year: 2014



Multidisciplinary evaluation of interstitial lung diseases: current insights
Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017
Year: 2017



Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018
Year: 2019



Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Source: Eur Respir J 2009; 33: 1485-1497
Year: 2009



Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006



Early origins of lung disease: towards an interdisciplinary approach
Source: Eur Respir Rev, 29 (157) 200191; 10.1183/16000617.0191-2020
Year: 2020



Current and new challenges in occupational lung diseases
Source: Eur Respir Rev, 26 (146) 170080; 10.1183/16000617.0080-2017
Year: 2017



Current and emerging approaches to the genetic diagnosis of chILDs
Source: International Congress 2014 – Interstitial lung disease (ILD) in children
Year: 2014



How to build a lung: latest advances and emerging themes in lung bioengineering
Source: Eur Respir J, 52 (1) 1601355; 10.1183/13993003.01355-2016
Year: 2018



Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010


An introduction to mitochondria in lung biology and disease
Source: International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease
Year: 2018


PET/CT in nononcological lung diseases: current applications and future perspectives
Source: Eur Respir Rev 2016; 25: 247-258
Year: 2016